関連する実験動画
Updated: Sep 10, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
入院および入院していない炎症性腸疾患患者の併発症に関連する要因:単一センターでの予備研究
Marco Vincenzo Lenti1,2, Alice Silvia Brera2, Giacomo Broglio1,2
1Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
Journal of multimorbidity and comorbidity
|August 27, 2025
まとめ
併発症は炎症性腸疾患 (IBD) で一般的であり,患者の60%以上が罹患しています. 高齢,女性,社会経済的地位などの要因は IBD の併発率の高さに関連しています.
科学分野:
- 胃腸内科
- 内科 医学
- 公衆衛生
背景:
- 炎症性腸疾患 (IBD) は,併発性疾患と頻繁に関連しています.
- IBDの流行と併発性に影響を与える要因を理解することは,患者の管理に極めて重要です.
研究 の 目的:
- 炎症性腸疾患 (IBD) の入院患者と非入院患者の併発症率を評価する.
- IBD患者における併発性に関連した臨床的および社会経済的要因を特定する.
主な方法:
- サン・マッテオ複合性 (SMAC) 研究 (2017年−2019年) による,入院IBD患者と,性別と年齢を合わせたIBD患者 (2:1比) の比較研究.
- 年齢,性別,弱さ,収入,教育,多剤薬剤を含む臨床的および社会経済的要因との関連性に関する共病率の評価
主要な成果:
- 104人のIBD患者の60. 6%が併発症しており,入院した患者 (66. 6%) と入院していない患者 (58. 5%) の割合がわずかに高かった.
- 併発症患者は高齢で,疾患の重症度 (CIRSスコア) が高く,女性の方が多く,より弱体で,教育レベルが低い.
- 双変数分析では,65歳以上の年齢,女性,収入1000ユーロ未満,学校教育8年未満,脆弱性,および多剤薬学が併発症に関連する要因として特定されました.
結論:
- 炎症性腸疾患 (IBD) の患者では,併発症率が高い.
- 低社会経済的地位と低い教育水準は IBD の併発性の負担に大きく寄与する要因である可能性があります.
関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
382
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
382
Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
Irritable Bowel Syndrome I: Introduction
375
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
375
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189

